azosemide has been researched along with natriuretic peptide, brain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furusho, Y; Hamasaki, S; Ikeda, Y; Kubozono, T; Kusumoto, A; Miyata, M; Sasaki, T; Shinsato, T; Tei, C | 1 |
| Akasaka, T; Daimon, T; Fukui, M; Hirano, Y; Hirotani, S; Ito, H; Kawabata, M; Masuyama, T; Nakatani, S; Ohte, N; Tsujino, T; Yamamoto, K | 1 |
| Kikuchi, S; Kitada, S; Masuyama, T; Ohte, N; Tsujino, T | 1 |
3 trial(s) available for azosemide and natriuretic peptide, brain
| Article | Year |
|---|---|
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardiography; Female; Furosemide; Heart Failure; Heart Function Tests; Humans; Male; Natriuretic Peptide, Brain; Outpatients; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides | 2012 |
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Failure; Humans; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides | 2017 |
The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
Topics: Aged; Biomarkers; Cardiac Catheterization; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Natriuretic Peptide, Brain; Prognosis; Prospective Studies; Risk Factors; Single-Blind Method; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfanilamides; Ventricular Function, Left | 2018 |